Menu

Search
Close this search box.

PM lauds Malaysia’s stance on Palestine issue

Prime Minister Muhammad Shehbaz Sharif exchanged Eid greetings with the Prime Minister of Malaysia Datuk Seri Anwar Ibrahim.

The Prime Minister conveyed his sincere wishes and prayers for the prosperity and progress of the fraternal people of Malays…

Read More

Govt requests people to ensure safe disposal of offal

Government has issued an awareness message requesting people to ensure safe disposal of offal and remains of sacrificial animals at designated places to avoid bird-aircraft collision risk.

According to the message, the public is requested to avoid t…

Read More

PM felicitates military leadership on Eid ul Azha

Prime Minister Shehbaz Sharif spoke to Military leadership of the country over telephone today to congratulate them Eid ul Azha.

He telephoned Joint Chiefs of Staff Committee General Sahir Shamshad Mirza, Chief of Army Staff General Syed Asim Munir,…

Read More

Pakistan, Kazakhstan to expand bilateral cooperation

Pakistan and Kazakhstan have reaffirmed shared desire to expand cooperation between both countries to its full potential, particularly in trade and investment.

The commitment was expressed by Prime Minister Muhammad Shehbaz Sharif and President of t…

Read More

ADSK ANNOUNCEMENT: If You Have Suffered Losses in Autodesk, Inc. (NASDAQ: ADSK), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Autodesk, Inc. (NASDAQ: ADSK) between June 1, 2023 and April 16, 2024, both dates inclusive (the “Class Period”), shareholders who want to serve as lead plaintiff for the class must file their […]

Read More

ALT ANNOUNCEMENT: If You Have Suffered Losses in Altimmune, Inc. (NASDAQ: ALT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, June 16, 2024 (GLOBE NEWSWIRE) — Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Altimmune, Inc. (NASDAQ: ALT) between December 1, 2023 and April 26, 2024, both dates inclusive (the “Class Period”), shareholders who want to serve as lead plaintiff for the class must file their motions […]

Read More